Position in REPL
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$2,210,000
+$1,152,435 QoQ
Shares Held
288,889
+165.5% QoQ
Ownership
0.344%
of shares outstanding
% of Portfolio
0.07%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2025
4 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in REPL Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026SummitTX Capital, L.P. holds $204,820,246 across 62 Biotechnology names. REPL ranks #29 (1.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | TERN |
Terns Pharmaceuticals, Inc.
|
312,181 | $16,458,182 | |
| 2 | RYTM |
Rhythm Pharmaceuticals, Inc.
|
165,599 | $14,402,145 | |
| 3 | JAZZ |
Jazz Pharmaceuticals plc
|
73,222 | $13,842,619 | |
| 4 | PRAX |
Praxis Precision Medicines, Inc.
|
36,838 | $11,868,835 | |
| 5 | COGT |
Cogent Biosciences, Inc.
|
293,780 | $11,307,592 | |
| 6 | PHAT |
Phathom Pharmaceuticals, Inc.
|
995,885 | $11,064,282 | |
| 7 | INBX |
Inhibrx Biosciences, Inc.
|
137,821 | $9,265,705 | |
| 8 | DNTH |
Dianthus Therapeutics, Inc. /DE/
|
100,044 | $8,395,692 |
All Filings in REPL
Export CSV
4 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $2,210,000 | 288,889 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $1,057,565 | 108,803 | Shares | Sole | 2026-02-17 | |
| 2025-06-30 | $642,886 | 69,202 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $1,063,442 | 109,071 | Shares | Defined | 2025-05-15 | |
| No filing history on record for this holder in this stock. | ||||||